Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease
Clinical trial NCT01850381 · COMPLETED
Trial details
- NCT number
- NCT01850381
- Sponsor
- Genervon Biopharmaceuticals, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-07-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.